Blog · corpus.blog/blogs/ipscell.com/posts
ipscell.com
ipscell.com
2026
Mitochondrial transfer or “mitotherapy” for disease & longevity: how much real hope vs. hype?original ↗
24 Sept 2026
Weekly reads: Longeveron MSC trial disappoints, CRISPR ancestor VIPR, distinct human brain progenitors, FDA staffing woesoriginal ↗
20 Sept 2026
Amid patient deaths and adverse events Japan needs to tackle its unproven regenerative clinicsoriginal ↗
16 Sept 2026
13 Sept 2026
Weekly reads: Stanford prof Mike Snyder & peptide cream, microglia aged out, CRISPR dogs, instrumented organoidsoriginal ↗
6 Sept 2026
Weekly reads: aging clocks under the gun, more on R3 Stem warning, Capricor update, FDA perinatal tissue setbackoriginal ↗
30 Aug 2026
Key FDA victory on stem cell clinics: permanent injunction against Cell Surgical Network, et al.original ↗
28 Aug 2026
Big implications for clinic arena from FDA warning to R3 Stem Cell, David Greene, & associated firmsoriginal ↗
26 Aug 2026
Weekly reads: Heidi Overton FDA commish nominee, NASA stem cells, aged brain organoids, cautious Nature iPS cell editorialoriginal ↗
23 Aug 2026